Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Stacy J. Park"'
Autor:
Bin Liu, Rui Li, Edward B Garon, Steven M Dubinett, Kostyantyn Krysan, Tianhao Zhang, Aaron E Lisberg, Ramin Salehi-Rad, Raymond J Lim, Yushen Du, Linh M Tran, Stephanie L Ong, Zi Ling Huang, Camelia Dumitras, Stacy J Park, William Crosson, Bitta Kahangi, Jensen Abascal, Christopher Seet, Michael Oh, Maryam Shabihkhani, Manash Paul
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 9 (2023)
Background Despite recent advances in immunotherapy, many patients with non-small cell lung cancer (NSCLC) do not respond to immune checkpoint inhibitors (ICI). Resistance to ICI may be driven by suboptimal priming of antitumor T lymphocytes due to p
Externí odkaz:
https://doaj.org/article/bf2a559715ab4836a9534c935ea67e88
Autor:
Steven M. Dubinett, Tonya C. Walser, John D. Minna, Dino Di Carlo, James K. Gimzewski, Michael C. Fishbein, Atsuko Seki, Shaina Hakimi, Jill E. Larsen, Yari Fontebasso, Manash K. Paul, Kostyantyn Krysan, Rui Li, Zhe Jing, Elvira L. Liclican, Stacy J. Park, Jonathan W. Hoech, Shivani Sharma, Henry T. Tse, Sean O'Byrne, Nawal Bendris, Linh M. Tran, Paul C. Pagano
Lung cancers are documented to have remarkable intratumoral genetic heterogeneity. However, little is known about the heterogeneity of biophysical properties, such as cell motility, and its relationship to early disease pathogenesis and micrometastat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ffe8a4187bc54cc259584bd0cf927434
https://doi.org/10.1158/1940-6207.c.6547270.v1
https://doi.org/10.1158/1940-6207.c.6547270.v1
Autor:
Steven M. Dubinett, John D. Minna, Jill E. Larsen, Brian K. Gardner, Paul C. Pagano, Stacy J. Park, Kostyantyn Krysan, Saswati Hazra, Tonya C. Walser, Elvira L. Liclican
PDF file - 10K, miR-125a expression in human tissue (normal and premalignant atypical adenomatous hyperplasia lesions).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46dc03527f1d8e6a49ef5fb288b51b45
https://doi.org/10.1158/1940-6207.22525338
https://doi.org/10.1158/1940-6207.22525338
Autor:
Steven M. Dubinett, Tonya C. Walser, John D. Minna, Dino Di Carlo, James K. Gimzewski, Michael C. Fishbein, Atsuko Seki, Shaina Hakimi, Jill E. Larsen, Yari Fontebasso, Manash K. Paul, Kostyantyn Krysan, Rui Li, Zhe Jing, Elvira L. Liclican, Stacy J. Park, Jonathan W. Hoech, Shivani Sharma, Henry T. Tse, Sean O'Byrne, Nawal Bendris, Linh M. Tran, Paul C. Pagano
Supplemental Tables, Figures, and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::528552045ec7bdf8e9fe6aeb718896dc
https://doi.org/10.1158/1940-6207.22533850
https://doi.org/10.1158/1940-6207.22533850
Autor:
Steven M. Dubinett, John D. Minna, Jill E. Larsen, Brian K. Gardner, Paul C. Pagano, Stacy J. Park, Kostyantyn Krysan, Saswati Hazra, Tonya C. Walser, Elvira L. Liclican
Understanding the molecular pathogenesis of lung cancer is necessary to identify biomarkers/targets specific to individual airway molecular profiles and to identify options for targeted chemoprevention. Herein, we identify mechanisms by which loss of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14b1e023f11b1b8f32cbdfb3e584f1be
https://doi.org/10.1158/1940-6207.c.6544692
https://doi.org/10.1158/1940-6207.c.6544692
Autor:
Steven M. Dubinett, Bin Liu, Linh M. Tran, David B. Shackelford, Kostyantyn Krysan, Stacy J. Park, Zhe Jing, Camelia Dumitras, Jensen Abascal, Tianhao Zhang, Zi Ling Huang, Stephanie L. Ong, Raymond J. Lim, Milica Momcilovic, William Crosson, Ramin Salehi-Rad, Rui Li
Gene-Specific Primers and Flow Antibodies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bb25a239f92343f7791ddd75a6b9e7f
https://doi.org/10.1158/0008-5472.22429215
https://doi.org/10.1158/0008-5472.22429215
Autor:
Steven M. Dubinett, Bin Liu, Linh M. Tran, David B. Shackelford, Kostyantyn Krysan, Stacy J. Park, Zhe Jing, Camelia Dumitras, Jensen Abascal, Tianhao Zhang, Zi Ling Huang, Stephanie L. Ong, Raymond J. Lim, Milica Momcilovic, William Crosson, Ramin Salehi-Rad, Rui Li
Supplemental Figures S1-S6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b1a6c3e6608e67ea6eb1b913a81e365
https://doi.org/10.1158/0008-5472.22429218
https://doi.org/10.1158/0008-5472.22429218
Autor:
Steven M. Dubinett, Bin Liu, Linh M. Tran, David B. Shackelford, Kostyantyn Krysan, Stacy J. Park, Zhe Jing, Camelia Dumitras, Jensen Abascal, Tianhao Zhang, Zi Ling Huang, Stephanie L. Ong, Raymond J. Lim, Milica Momcilovic, William Crosson, Ramin Salehi-Rad, Rui Li
LKB1 inactivating mutations are commonly observed in patients with KRAS-mutant non–small cell lung cancer (NSCLC). Although treatment of NSCLC with immune checkpoint inhibitors (ICI) has resulted in improved overall survival in a subset of patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92a10b2302ae70ae96438565171e6f5f
https://doi.org/10.1158/0008-5472.c.6513285.v1
https://doi.org/10.1158/0008-5472.c.6513285.v1
Autor:
Ramin Salehi-Rad, Gina Lee, Linh M. Tran, Kostyantyn Krysan, Tonya C. Walser, William P. Crosson, Shili Xu, Zhe Jing, Stacy J. Park, Steven M. Dubinett, Bin Liu, Stephanie L. Ong, Harvey R. Herschman, Eileen L. Heinrich, Manash K. Paul, Paul Pagano, Rui Li, Zi Ling Huang
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-15 (2020)
Scientific reports, vol 10, iss 1
Scientific Reports
Scientific reports, vol 10, iss 1
Scientific Reports
Chronic inflammation facilitates tumor progression. We discovered that a subset of non-small cell lung cancer cells underwent a gradually progressing epithelial-to-mesenchymal (EMT) phenotype following a 21-day exposure to IL-1β, an abundant proinfl
Autor:
Bin Liu, Maryam Shabihkhani, Stephanie L. Ong, Steven M. Dubinett, Milica Momcilovic, Linh M. Tran, Kostyantyn Krysan, Ramin Salehi-Rad, Stacy J. Park, Rui Li, David B. Shackelford, Zi Ling Huang, Raymond J. Lim, Jensen Abascal, Manash K. Paul
Publikováno v:
Cancer immunology, immunotherapy : CII, vol 70, iss 8
Cancer Immunology, Immunotherapy
Cancer Immunology, Immunotherapy
Conditional genetically engineered mouse models (GEMMs) of non-small cell lung cancer (NSCLC) harbor common oncogenic driver mutations of the disease, but in contrast to human NSCLC these models possess low tumor mutational burden (TMB). As a result,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afe2934c35a6059eda5971dc13b78d17
https://escholarship.org/uc/item/0nb5s9nd
https://escholarship.org/uc/item/0nb5s9nd